Migration of Durasphere after Transurethral Injection for Stress Urinary Incontinence

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


Background: Stress urinary incontinence in women can be treated by injectable bulking agents. Durasphere is promoted as a nonantigenic, noncarcinogenic and nonmigratory substance. Case History: A 67-year-old-woman underwent multiple treatments for stress urinary incontinence, including 2 periurethral injections of Durasphere. Several months later, a voiding cystogram, ordered to assess her persistent incontinence, revealed Durasphere beads on each side of the urethra as well as in the adjacent lymphatic channels. Conclusion: This case report underlines the potential hazard of particle migration with this agent.

Original languageEnglish (US)
Pages (from-to)39-40
Number of pages2
JournalJournal of Pelvic Medicine and Surgery
Issue number1
StatePublished - Mar 30 2004


  • Bulking agent
  • Durasphere
  • Migration
  • Urinary incontinence

ASJC Scopus subject areas

  • Surgery
  • Obstetrics and Gynecology
  • Urology


Dive into the research topics of 'Migration of Durasphere after Transurethral Injection for Stress Urinary Incontinence'. Together they form a unique fingerprint.

Cite this